AKT1 and Miyoshi myopathy: Targeting other molecules within the JAK/STAT3 cascade also appears to aid in resistance reversal, as the Akt inhibitor, MK2206, has also been found to help overcome bortezomib resistance in MM cells induced by co-culturing with IL-6 or MSCs (176).